Geneos Wealth Management’s First Trust Mid Cap Value AlphaDEX Fund FNK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$137K Hold
2,400
﹤0.01% 1079
2025
Q4
$134K Hold
2,400
﹤0.01% 1065
2025
Q3
$133K Hold
2,400
﹤0.01% 1031
2025
Q2
$124K Sell
2,400
-800
-25% -$39.4K ﹤0.01% 1162
2025
Q1
$161K Buy
3,200
+2,400
+300% +$127K ﹤0.01% 1329
2024
Q4
$42.8K Hold
800
﹤0.01% 1380
2024
Q3
$43.6K Hold
800
﹤0.01% 1250
2024
Q2
$40.8K Hold
800
﹤0.01% 1136
2024
Q1
$43.3K Hold
800
﹤0.01% 1115
2023
Q4
$40.8K Hold
800
﹤0.01% 1122
2023
Q3
$35.7K Hold
800
﹤0.01% 1179
2023
Q2
$36.6K Hold
800
﹤0.01% 1182
2023
Q1
$35K Hold
800
﹤0.01% 1178
2022
Q4
$34.4K Hold
800
﹤0.01% 1177
2022
Q3
$30K Hold
800
﹤0.01% 1196
2022
Q2
$32K Buy
800
+400
+100% +$17.7K ﹤0.01% 1471
2022
Q1
$18K Buy
+400
New +$18.5K ﹤0.01% 1849

Other funds holding FNK

Geneos Wealth Management's FNK Position: Q1 2026 in Review

Geneos Wealth Management held its First Trust Mid Cap Value AlphaDEX Fund (FNK) position steady in Q1 2026 at 2,400 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Geneos Wealth Management first reported a position in FNK in Q1 2022 and has held it in 17 quarters since. The position peaked at $161K in Q1 2025. 59 funds tracked by Wall St. Rank hold FNK as of Q1 2026.

  • Geneos Wealth Management held 2,400 shares of First Trust Mid Cap Value AlphaDEX Fund worth $137K as of Q1 2026.
  • Geneos Wealth Management left its First Trust Mid Cap Value AlphaDEX Fund share count unchanged in Q1 2026.
  • First Trust Mid Cap Value AlphaDEX Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1079 holding.
  • Geneos Wealth Management first reported a position in First Trust Mid Cap Value AlphaDEX Fund in Q1 2022 and has held it in 17 quarters since.
  • Geneos Wealth Management's First Trust Mid Cap Value AlphaDEX Fund position peaked at $161K in Q1 2025.
  • 59 funds tracked by Wall St. Rank held First Trust Mid Cap Value AlphaDEX Fund as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.